Pharmacologic evidence for involvement of phospholipase C in pemphigus IgG-induced inositol 1,4,5-trisphosphate generation, intracellular calcium increase, and plasminogen activator secretion in DJM-1 cells, a squamous cell carcinoma line.

The precise mechanism for acantholysis after pemphigus IgG binds to the cell surface is as yet unknown, although involvement of proteinases such as plasminogen activator (PA) has been suggested. We previously reported that pemphigus IgG, but not normal nor bullous pemphigoid IgGs, caused a transient increase in intracellular calcium ([Ca++]i) and inositol 1,4,5-trisphosphate (IP3) concentration in cultured DJM-1 cells (a squamous cell carcinoma line). To clarify whether phospholipase C is involved in this process after the antibody binds to the cell surface, we examined the effects of a specific phospholipase C inhibitor (U73122) on the pemphigus IgG-induced increase in [Ca++]i, IP3, PA secretion, and cell-cell detachment in DJM-1 cells. [Ca+2]i and IP3 contents were determined with or without 30-min pre-incubation with U73122 or an inactive analogue (U73343) with fura-2 acetoxymethylester and a specific IP3 binding protein, respectively. PA activity in the culture medium was measured after various incubation periods with pemphigus IgG by two-step amidolytic assay. The detachment of cell-cell contacts was examined by detecting the retraction of keratin filament bundle from cell-cell contact points to the perinuclear region by immunofluorescence microscopy using anti-keratin antibody. Pemphigus IgG immediately increased [Ca++]i and IP3 content. PA activity in the culture medium has also been increased at 24 h after pemphigus IgG was added in association with cell-cell detachment. However, pre-incubation with U73122 (1-10 microM), but not with U73343 (10 microM), dramatically reduced the pemphigus IgG-induced increases in [Ca++]i, IP3, and PA activity and inhibited the pemphigus IgG-induced cell-cell detachment. Both U73122 and U73343 caused no effects on cell viability and IgG binding to the cell surface. These results suggest that phospholipase C plays an important role in transmembrane signaling leading to cell-cell detachment exerted by pemphigus IgG binding to the cell surface.

[1]  F. Crameri,et al.  Calcium‐independent increases in pericellular plasminogen activator activity in pemphigus vulgaris * , 1993, Experimental dermatology.

[2]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[3]  S. Rhee,et al.  Activation of the β1 isozyme of phospholipase C by α subunits of the Gq class of G proteins , 1991, Nature.

[4]  K. Owaribe,et al.  A possible cell-biologic mechanism involved in blister formation of bullous pemphigoid: anti-180-kD BPA antibody is an initiator. , 1994, Dermatology.

[5]  M. Hagiwara,et al.  Bradykinin-induced translocation of protein kinases C in neuroblastoma NCB-20 cell: dependence on 1,2-diacylglycerol content and free calcium. , 1989, Biochemical and biophysical research communications.

[6]  D. Proud,et al.  Dexamethasone inhibits plasminogen activator activity in experimental pemphigus in vivo but does not block acantholysis. , 1986, Journal of Immunology.

[7]  W. Franke,et al.  Nomenclature of the desmosomal cadherins , 1993, The Journal of cell biology.

[8]  J. Stanley,et al.  Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen. , 1988, The Journal of clinical investigation.

[9]  T. Nishikawa,et al.  Detection of pemphigus vulgaris and pemphigus foliaceus antigens by immunoblot analysis using different antigen sources. , 1990, The Journal of investigative dermatology.

[10]  R. Smith,et al.  Receptor-coupled signal transduction in human polymorphonuclear neutrophils: effects of a novel inhibitor of phospholipase C-dependent processes on cell responsiveness. , 1990, The Journal of pharmacology and experimental therapeutics.

[11]  F. Fitzpatrick,et al.  Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. , 1990, The Journal of pharmacology and experimental therapeutics.

[12]  K. Hashimoto,et al.  Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation , 1983, The Journal of experimental medicine.

[13]  K. Owaribe,et al.  Antibody‐Binding to the 180‐kD Bullous Pemphigoid Antigens at the Lateral Cell Surface Causes Their Internalization and Inhibits Their Assembly at the Basal Cell Surface in Cultured Keratinocytes , 1994, The Journal of dermatology.

[14]  E. Modest,et al.  Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues. , 1992, Cancer research.

[15]  T. Hashimoto,et al.  Pemphigus IgG, but not bullous pemphigoid IgG, causes a transient increase in intracellular calcium and inositol 1,4,5-triphosphate in DJM-1 cells, a squamous cell carcinoma line. , 1995, The Journal of investigative dermatology.

[16]  Y. Kitajima,et al.  Effects of pemphigus antibody on the regeneration of cell-cell contact in keratinocyte cultures grown in low to normal Ca++ concentration. , 1987, The Journal of investigative dermatology.

[17]  H. Ogawa,et al.  The pathogenic role of pemphigus antibodies and proteinase in epidermal acantholysis. , 1981, The Journal of investigative dermatology.

[18]  D. C. Livingston,et al.  A quantitative assay for the activation of plasminogen by transformed cells in situ and by urokinase. , 1981, Biochemistry.

[19]  R. Smallridge,et al.  U-73122, an aminosteroid phospholipase C antagonist, noncompetitively inhibits thyrotropin-releasing hormone effects in GH3 rat pituitary cells. , 1992, Endocrinology.

[20]  Y. Nozawa,et al.  Defective formation of inositol 1,4,5-trisphosphate in bradykinin-stimulated fibroblasts from progressive systemic sclerotic patients. , 1988, Biochemical and biophysical research communications.

[21]  T. Fleming,et al.  The calcium signal for Balb/MK keratinocyte terminal differentiation induces sustained alterations in phosphoinositide metabolism without detectable protein kinase C activation. , 1989, The Journal of biological chemistry.

[22]  N. Korman,et al.  Demonstration of an adhering-junction molecule (plakoglobin) in the autoantigens of pemphigus foliaceus and pemphigus vulgaris. , 1989, The New England journal of medicine.

[23]  Y. Nozawa,et al.  Biphasic effects of 12-O-tetradecanoylphorbol-13-acetate on the cell morphology of low calcium-grown human epidermal carcinoma cells: involvement of translocation and down regulation of protein kinase C. , 1988, Cancer research.

[24]  G. Lazarus,et al.  Molecular mechanisms of pathogenesis. , 1983, Clinics in dermatology.

[25]  J. Fraki,et al.  Correlation of epidermal plasminogen activator activity with disease activity in psoriasis , 1983, The British journal of dermatology.

[26]  L. Denlinger,et al.  The aminosteroid U-73122 inhibits muscarinic receptor sequestration and phosphoinositide hydrolysis in SK-N-SH neuroblastoma cells. A role for Gp in receptor compartmentation. , 1991, The Journal of biological chemistry.

[27]  P C Sternweis,et al.  Regulation of polyphosphoinositide-specific phospholipase C activity by purified Gq. , 1991, Science.

[28]  K. Cehrs,et al.  Pemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomes , 1993, The Journal of cell biology.

[29]  J. Williams,et al.  U73122 inhibits Ca2+ oscillations in response to cholecystokinin and carbachol but not to JMV-180 in rat pancreatic acinar cells. , 1992, The Journal of biological chemistry.

[30]  Y. Nishizuka.  Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. , 1992, Science.